What is the starting dose of propranolol (beta-blocker) for tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol Starting Dose for Tachycardia

The starting dose of propranolol for tachycardia is 0.5 to 1 mg IV over 1 minute, which can be repeated up to a total dose of 0.1 mg/kg as required. 1

Dosing Guidelines Based on Administration Route

Intravenous (IV) Administration

  • Initial dose: 0.5-1 mg administered over 1 minute
  • May repeat doses up to a total cumulative dose of 0.1 mg/kg if required
  • Allow at least 1-2 minutes between doses to assess response

Oral Administration

  • For stable narrow-complex tachycardias:
    • Starting dose: 10-40 mg, 3-4 times daily
    • Maintenance dose can be adjusted based on clinical response

Indications for Propranolol in Tachycardia

Propranolol is indicated for:

  • Stable narrow-complex tachycardias unresponsive to adenosine or vagal maneuvers
  • Rate control in atrial fibrillation or flutter
  • Certain forms of polymorphic ventricular tachycardia (associated with acute ischemia, familial LQTS, or catecholaminergic VT) 1

Mechanism of Action

Propranolol works as a non-selective beta-blocker that:

  • Reduces effects of circulating catecholamines
  • Decreases heart rate and AV node conduction
  • Lowers blood pressure
  • Has negative inotropic effects 1

Important Contraindications and Precautions

Propranolol should be avoided in patients with:

  • Asthma or obstructive airway disease
  • Decompensated heart failure
  • Pre-excited atrial fibrillation or flutter 1
  • Second or third-degree heart block 1

Monitoring Parameters

  • Heart rate and blood pressure should be monitored during initial administration
  • For IV administration, continuous cardiac monitoring is recommended
  • Observe for signs of hypotension, bradycardia, or heart failure

Special Considerations

  1. Dose adjustment in liver disease: Patients with severe liver disease (serum albumin <30 g/L) may require lower starting doses due to reduced clearance 2

  2. Biphasic response: Some patients may exhibit a biphasic dose-response curve, with increased arrhythmias at higher doses 3

  3. Low vs. high dose efficacy: For some conditions like postural tachycardia syndrome (POTS), lower doses (20 mg) may provide better symptom relief than higher doses (80 mg), despite greater heart rate reduction with higher doses 4

By following these guidelines, propranolol can be effectively used to manage various forms of tachycardia while minimizing the risk of adverse effects.

Related Questions

What is the role of propranolol (beta-blocker) in managing arrhythmias, specifically supraventricular tachycardias and ventricular arrhythmias?
What is the appropriate dosage and management of propanolol (beta blocker) for treating palpitations?
Can a patient with tachycardia be given propranolol (beta blocker)?
What is the recommended dosage of propranolol (beta-blocker) for palpitations and tachycardia in the context of elevated Free Triiodothyronine (FT3) hormone levels in the Emergency Room (ER) setting?
What is the typical dosage of propranolol (beta-blocker) based on weight for managing palpitations?
What treatment is recommended for an 80-year-old patient with a mucus retention cyst and chronic rhinitis symptoms already on fluticasone (fluticasone) twice daily?
Should thyroid antibodies, such as Thyroid Peroxidase Antibodies (TPOAb) and Thyroglobulin Antibodies (TgAb), be ordered in a patient with a normal Thyroid-Stimulating Hormone (TSH) level to investigate for possible Hashimoto's thyroiditis?
What are the most common medications involved in serotonin syndrome, including Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Monoamine Oxidase Inhibitors (MAOIs), and triptans?
What are the most common medications involved in Neuroleptic Malignant Syndrome (NMS)?
Is it safe to tickle babies?
What are the next steps in managing a patient with subcentimeter pulmonary nodules, a partially visualized hypodensity in the left renal cortex, scattered colonic diverticulosis, and mild spine degenerative changes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.